You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Nafcillin sodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for nafcillin sodium and what is the scope of patent protection?

Nafcillin sodium is the generic ingredient in five branded drugs marketed by Wyeth Ayerst, Antibiotice, Apothecon, Eugia Pharma Speclts, Fresenius, Istituto Bio Ita Spa, Sagent Pharms, Sandoz, Steriscience Speclts, Watson Labs Inc, Glaxosmithkline, and Baxter Hlthcare, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for nafcillin sodium. Ten suppliers are listed for this compound.

Summary for nafcillin sodium
US Patents:0
Tradenames:5
Applicants:12
NDAs:23
Drug Master File Entries: 9
Finished Product Suppliers / Packagers: 10
Raw Ingredient (Bulk) Api Vendors: 117
Clinical Trials: 1
Patent Applications: 2,805
What excipients (inactive ingredients) are in nafcillin sodium?nafcillin sodium excipients list
DailyMed Link:nafcillin sodium at DailyMed
Recent Clinical Trials for nafcillin sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4

See all nafcillin sodium clinical trials

Pharmacology for nafcillin sodium
Medical Subject Heading (MeSH) Categories for nafcillin sodium

US Patents and Regulatory Information for nafcillin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eugia Pharma Speclts NAFCILLIN SODIUM nafcillin sodium INJECTABLE;INJECTION 091614-001 Dec 26, 2012 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst UNIPEN nafcillin sodium INJECTABLE;INJECTION 050320-004 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline NALLPEN nafcillin sodium INJECTABLE;INJECTION 062755-002 Dec 19, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst UNIPEN nafcillin sodium INJECTABLE;INJECTION 050320-005 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs Inc NAFCILLIN SODIUM nafcillin sodium INJECTABLE;INJECTION 062844-002 Oct 26, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Steriscience Speclts NAFCILLIN SODIUM nafcillin sodium INJECTABLE;INJECTION 200002-002 Apr 7, 2014 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Steriscience Speclts NAFCILLIN SODIUM nafcillin sodium INJECTABLE;INJECTION 200002-001 Apr 7, 2014 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.